Guo, S.; Bai, X.; Shi, S.; Deng, Y.; Kang, X.; An, H.
TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. Int. J. Mol. Sci. 2021, 22, 10930.
https://doi.org/10.3390/ijms222010930
AMA Style
Guo S, Bai X, Shi S, Deng Y, Kang X, An H.
TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. International Journal of Molecular Sciences. 2021; 22(20):10930.
https://doi.org/10.3390/ijms222010930
Chicago/Turabian Style
Guo, Shuai, Xue Bai, Sai Shi, Yawen Deng, Xianjiang Kang, and Hailong An.
2021. "TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment" International Journal of Molecular Sciences 22, no. 20: 10930.
https://doi.org/10.3390/ijms222010930
APA Style
Guo, S., Bai, X., Shi, S., Deng, Y., Kang, X., & An, H.
(2021). TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. International Journal of Molecular Sciences, 22(20), 10930.
https://doi.org/10.3390/ijms222010930